Dexbrompheniramine Maleate
1 NDC across 1 manufacturer|1 Generic,0 Brand
Dexbrompheniramine Maleate is used to treat common cold, rhinitis, allergic, perennial, sinusitis and urticaria, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982.
Dexbrompheniramine Maleate is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.66 to $0.66 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.66 – $0.66
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DEXBROMPHENIRAMINE MALEATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ALA-HIST IR 2 MG TABLET | $0.6606 per EA | — |
Frequently Asked Questions
What is Dexbrompheniramine Maleate used to treat?
Dexbrompheniramine Maleate is used to treat common cold, rhinitis, allergic, perennial, sinusitis and urticaria, per the National Library of Medicine's MED-RT classification.
How many Dexbrompheniramine Maleate products are on the market?
The Dexbrompheniramine Maleate drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Dexbrompheniramine Maleate?
NADAC reference prices for Dexbrompheniramine Maleate range from $0.6606 to $0.6606 per EA.
Which manufacturers make Dexbrompheniramine Maleate?
1 manufacturer lists Dexbrompheniramine Maleate in NADAC. Ranked by number of NDCs, the largest are Poly Pharmaceuticals, Inc. (1).